{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T18:15:58Z","timestamp":1775672158210,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T00:00:00Z","timestamp":1611360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T00:00:00Z","timestamp":1611360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s11030-021-10182-x","type":"journal-article","created":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T16:03:21Z","timestamp":1611417801000},"page":"769-780","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Design, synthesis, and preliminary pharmacological evaluation of novel thiazolidinone derivatives as potential benzodiazepine agonists"],"prefix":"10.1007","volume":"26","author":[{"given":"Ali","family":"Almasirad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Ghadimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeideh","family":"Mirahmadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pouya","family":"Ahmadian Kodakan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Jahani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Nazari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elham","family":"Rezaee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Homa","family":"Azizian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parmida","family":"Rabizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayyed Abbas","family":"Tabatabai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehrdad","family":"Faizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,23]]},"reference":[{"key":"10182_CR1","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/S0140-6736(19)30934-1","volume":"394","author":"F Charlson","year":"2019","unstructured":"Charlson F, Ommeren M, Flaxman A, Cornett J, Whiteford H, Saxena S (2019) New WHO prevalence estimates of mental disorders in conflict settings: a systematic review and meta-analysis. Lancet 394:240\u2013248. https:\/\/doi.org\/10.1016\/S0140-6736(19)30934-1","journal-title":"Lancet"},{"key":"10182_CR2","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.jpainsymman.2019.01.010","volume":"57","author":"SB O\u2019Donnell","year":"2019","unstructured":"O\u2019Donnell SB, Nicholson MK, Boland JW (2019) The association between benzodiazepines and survival in patients with cancer: a systematic review. J Pain Symptom Manag 57:999-1008.e11. https:\/\/doi.org\/10.1016\/j.jpainsymman.2019.01.010","journal-title":"J Pain Symptom Manag"},{"key":"10182_CR3","doi-asserted-by":"publisher","first-page":"e1002635","DOI":"10.1371\/journal.pmed.1002635","volume":"15","author":"A Sidorchuk","year":"2018","unstructured":"Sidorchuk A, Isomura K, Molero Y, Hellner C, Lichtenstein P, Chang Z, Franck J, Fern\u00e1ndez de la Cruz L, Mataix-Cols D (2018) Benzodiazepine prescribing for children, adolescents, and young adults from 2006 through 2013: a total population register-linkage study. PLoS Med 15:e1002635. https:\/\/doi.org\/10.1371\/journal.pmed.1002635","journal-title":"PLoS Med"},{"key":"10182_CR4","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.bmc.2014.12.016","volume":"23","author":"M Faizi","year":"2015","unstructured":"Faizi M, Dabirian S, Tajali H, Ahmadi F, Zavareh ER, Shahhosseini S, Tabatabai SA (2015) Novel agonists of benzodiazepine receptors: design, synthesis, binding assay and pharmacological evaluation of 1,2,4-triazolo [1,5-a]pyrimidinone and 3-amino-1,2,4-triazole derivatives. Bioorg Med Chem 23:480\u2013487. https:\/\/doi.org\/10.1016\/j.bmc.2014.12.016","journal-title":"Bioorg Med Chem"},{"key":"10182_CR5","doi-asserted-by":"publisher","first-page":"538","DOI":"10.4140\/TCP.n.2013.538","volume":"28","author":"JY Wick","year":"2013","unstructured":"Wick JY (2013) The history of benzodiazepines. Consult Pharm 28:538\u2013548. https:\/\/doi.org\/10.4140\/TCP.n.2013.538","journal-title":"Consult Pharm"},{"key":"10182_CR6","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1177\/1755738019869730","volume":"12","author":"D Gleeson","year":"2019","unstructured":"Gleeson D (2019) Benzodiazepines: dependence and addiction in general practice. InnovAiT 12:656\u2013663. https:\/\/doi.org\/10.1177\/1755738019869730","journal-title":"InnovAiT"},{"key":"10182_CR7","doi-asserted-by":"publisher","first-page":"103668","DOI":"10.1016\/j.bioorg.2020.103668","volume":"97","author":"N Arora","year":"2020","unstructured":"Arora N, Dhiman P, Kumar S, Singh G, Monga V (2020) Recent advances in synthesis and medicinal chemistry of benzodiazepines. Bioorg Chem 97:103668. https:\/\/doi.org\/10.1016\/j.bioorg.2020.103668","journal-title":"Bioorg Chem"},{"key":"10182_CR8","doi-asserted-by":"crossref","unstructured":"Galarneau DW, Conrad EJ (2015) Benzodiazepine intoxication and withdrawal: assessment and management. In: Deitelzweig S (ed) Hospital medicine clinics, Elsevier Inc, pp 513\u2013526","DOI":"10.1016\/j.ehmc.2015.06.005"},{"key":"10182_CR9","unstructured":"Ries RK, Fiellin DA, Miller SC, Salitz R (eds) (2009) Principles of addiction medicine, 4th edn. Lippincott Williams & Wilkins"},{"key":"10182_CR10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ejmech.2013.11.017","volume":"72","author":"AC Tripathi","year":"2014","unstructured":"Tripathi AC, Gupta SJ, Fatima GN, Sonar PK, Verma A, Saraf SK (2014) 4-Thiazolidinones: the advances continue. Eur J Med Chem 72:52\u201377. https:\/\/doi.org\/10.1016\/j.ejmech.2013.11.017","journal-title":"Eur J Med Chem"},{"key":"10182_CR11","unstructured":"Fryer RI (1990) Comprehensive medicinal chemistry. In: Hansch C (ed) Pergamon: Oxford, pp 539"},{"key":"10182_CR12","unstructured":"Neumeyer JL, Booth RG (1995) Principle of medicinal chemistry. In: Foye WO, Lemke TL, Williams DA (eds) Williams and Wilkins: Baltimore, p 221"},{"key":"10182_CR13","doi-asserted-by":"publisher","first-page":"6057","DOI":"10.1016\/j.bmcl.2004.09.072","volume":"14","author":"A Almasirad","year":"2004","unstructured":"Almasirad A, Tabatabai SA, Faizi M, Kebriaeezadeh A, Mehrabi N, Dalvandi A, Shafiee A (2004) Synthesis and anticonvulsant activity of new 2-substituted-5- [2-(2-fluorophenoxy)phenyl]-1,3,4-oxadiazoles and 1,2,4-triazoles. Bioorg Med Chem Lett 14:6057\u20136059. https:\/\/doi.org\/10.1016\/j.bmcl.2004.09.072","journal-title":"Bioorg Med Chem Lett"},{"key":"10182_CR14","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1016\/j.bmcl.2005.02.014","volume":"15","author":"A Zarghi","year":"2005","unstructured":"Zarghi A, Tabatabai SA, Faizi M, Ahadian A, Navabi P, Zanganeh V, Shafiee A (2005) Synthesis and anticonvulsant activity of new 2-substituted-5-(2-benzyloxyphenyl)-1,3,4-oxadiazoles. Bioorg Med Chem Lett 15:1863\u20131865. https:\/\/doi.org\/10.1016\/j.bmcl.2005.02.014","journal-title":"Bioorg Med Chem Lett"},{"key":"10182_CR15","unstructured":"Almasirad A, Vousooghi N, Tabatabai SA, Kebriaeezadeh A, Shafiee A (2007) Synthesis, anticonvulsant and muscle relaxant activities of substituted 1,3,4-oxadiazole, 1,3,4-thiadiazole and 1,2,4-triazole. Acta Chim Slovenica 54:317\u2013324. Available at: http:\/\/acta-arhiv.chem-soc.si\/54\/graph\/acta-54(2)-GA.htm"},{"key":"10182_CR16","unstructured":"Foroumadi A, Sheibani V, Sakhteman A, Rameshk M, Abbasi M, Farazifard R, Tabatabai S, Shafiee A (2007) Synthesis and anticonvulsant activity of novel 2-amino-5-[4-chloro-2-(2-chlorophenoxy) phenyl]- 1,3,4-thiadiazole derivatives. DARU J Pharm Sci 15:89\u201393. Available at: http:\/\/daru.tums.ac.ir\/index.php\/daru\/article\/view\/310"},{"key":"10182_CR17","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1248\/cpb.56.509","volume":"56","author":"A Zarghi","year":"2008","unstructured":"Zarghi A, Hajimahdi Z, Mohebbi S, Rashidi H, Mozaffari S, Sarraf S, Faizi M, Tabatabai SA, Shafiee A (2008) Design and synthesis of new 2-substituted- 5-[2-(2-halobenzyloxy)phenyl]-1, 3,4-oxadiazoles as anticonvulsant agents. Chem Pharm Bull 56:509\u2013512","journal-title":"Chem Pharm Bull"},{"key":"10182_CR18","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3797\/scipharm.0803-10","volume":"7","author":"A Zarghi","year":"2008","unstructured":"Zarghi A, Hamedi S, Tootooni F, Amini B, Sharifi B, Faizi M, Tabatabai SA, Shafiee A (2008) Synthesis and pharmacological evaluation of new 2-substituted-5-{2-[(2-halobenzyl)thiophenyl}-1,3,4-oxadiazoles as anticonvulsant agents. Sci Pharm 7:185\u2013202. https:\/\/doi.org\/10.3797\/scipharm.0803-10","journal-title":"Sci Pharm"},{"key":"10182_CR19","first-page":"265","volume":"9","author":"M Mahdavi","year":"2010","unstructured":"Mahdavi M, Akbarzadeh T, Sheibani V, Abbasi M, Firoozpour L, Tabatabai SA, Shafiee A, Foroumadi A (2010) Synthesis of two novel 3-amino-5-[4-chloro-2-phenoxyphenyl]-4h-1,2,4-triazoles with anticonvulsant activity. Iranian J Pharm Res 9:265\u2013269","journal-title":"Iranian J Pharm Res"},{"key":"10182_CR20","first-page":"83","volume":"11","author":"M Faizi","year":"2012","unstructured":"Faizi M, Sheikhha M, Ahangar N, Tabatabaei Ghomi H, Shafaghi B, Shafiee A, Tabatabai SA (2012) Design, synthesis and pharmacological evaluation of novel 2-[2-(2-chlorophenoxy)phenyl]-1,3,4-oxadiazole derivatives as benzodiazepine receptor agonists. Iran J Pharm Res 11:83\u201390 (PMID: 25317188)","journal-title":"Iran J Pharm Res"},{"key":"10182_CR21","doi-asserted-by":"publisher","first-page":"103","DOI":"10.18579\/jpcrkc\/2013\/12\/3\/79174","volume":"12","author":"SA Tabatabai","year":"2013","unstructured":"Tabatabai SA, Barghi Lashkari S, Zarrindast MR, Gholibeikian M, Shafiee A (2013) Design, synthesis and anticonvulsant activity of 2-(2-phenoxy) phenyl-1, 3, 4-oxadiazole derivatives. Iran J Pharm Res 12:103\u2013109 (PMID: 24250678)","journal-title":"Iran J Pharm Res"},{"key":"10182_CR22","doi-asserted-by":"publisher","first-page":"52","DOI":"10.17179\/excli2016-692","volume":"16","author":"M Faizi","year":"2017","unstructured":"Faizi M, Jahani R, Ebadi SA, Tabatabai SA, Rezaee E, Lotfaliei M, Amini M, Almasirad A (2017) Novel 4-thiazolidinone derivatives as agonists of benzodiazepine receptors: design, synthesis and pharmacological evaluation. EXCLI J 16:52\u201362. https:\/\/doi.org\/10.17179\/excli2016-692","journal-title":"EXCLI J"},{"key":"10182_CR23","doi-asserted-by":"publisher","first-page":"3714","DOI":"10.1021\/jm000942e","volume":"43","author":"P Ertl","year":"2000","unstructured":"Ertl P, Rohde B, Selzer P (2000) Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J Med Chem 43:3714\u20133717. https:\/\/doi.org\/10.1021\/jm000942e","journal-title":"J Med Chem"},{"key":"10182_CR24","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.ejmech.2006.12.022","volume":"42","author":"HJ Lankau","year":"2007","unstructured":"Lankau HJ, Unverferth K, Grunwald C, Hartenhauer H, Heinecke K, Bern\u00f6ster K, Dost R, Egerland U, Rundfeldt C (2007) New GABA-modulating 1,2,4-oxadiazole derivatives and their anticonvulsant activity. Eur J Med Chem 42:873\u2013879. https:\/\/doi.org\/10.1016\/j.ejmech.2006.12.022","journal-title":"Eur J Med Chem"},{"key":"10182_CR25","doi-asserted-by":"publisher","first-page":"4471","DOI":"10.1016\/j.bmc.2008.02.058","volume":"16","author":"G Guerrini","year":"2008","unstructured":"Guerrini G, Ciciani G, Cambi G, Bruni F, Selleri S, Melani F, Montali M, Martini C, Ghelardini C, Norcini M, Costanzo A (2008) Novel 3-aroylpyrazolo[5,1-c][1,2,4]benzotriazine 5-oxides 8-substituted, ligands at GABAA\/benzodiazepine receptor complex: synthesis, pharmacological and molecular modeling studies. Bioorg Med Chem 16:4471\u20134489. https:\/\/doi.org\/10.1016\/j.bmc.2008.02.058","journal-title":"Bioorg Med Chem"},{"key":"10182_CR26","doi-asserted-by":"publisher","first-page":"185","DOI":"10.5582\/ddt.2011.v5.4.185","volume":"5","author":"MO Raihan","year":"2011","unstructured":"Raihan MO, Habib MR, Brishti A, Rahman MM, Saleheen MM, Manna M (2011) Sedative and anxiolytic effects of the methanolic extract of Leea indica (Burm. f.). Merr leaf Drug Discovery Ther 5:185\u2013189. https:\/\/doi.org\/10.5582\/ddt.2011.v5.4.185","journal-title":"Merr leaf Drug Discovery Ther"},{"key":"10182_CR27","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1248\/yakushi.127.1263","volume":"127","author":"H Suleyman","year":"2007","unstructured":"Suleyman H, Guvenalp Z, Kizilkaya M, Demirezer LO (2007) Sedative effect of Centranthus longiflorus ssp. longiflorus in rats and the influence of adrenalectomy on its effect. Yakugaku Zasshi Pharm Soc Jpn 127:1263\u20131265. https:\/\/doi.org\/10.1248\/yakushi.127.1263","journal-title":"Yakugaku Zasshi Pharm Soc Jpn"},{"key":"10182_CR28","first-page":"565","volume":"35","author":"SK Bhattacharya","year":"1997","unstructured":"Bhattacharya SK, Satyan KS (1997) Experimental methods for evaluation of psychotropic agents in rodents: I-anti-anxiety agents. Indian J Exp Biol 35:565\u2013575 (PMID: 9357158)","journal-title":"Indian J Exp Biol"},{"key":"10182_CR29","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/jps.3030460322","volume":"46","author":"NM Dunham","year":"1957","unstructured":"Dunham NM, Miya TS (1957) A note on simple apparatus for detecting neurological deficit in rat and mice. J Am Pharm Ass 46:208\u2013209. https:\/\/doi.org\/10.1002\/jps.3030460322","journal-title":"J Am Pharm Ass"},{"key":"10182_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-662-03333-3","volume-title":"Drug discovery and evaluation (pharmacological assay)","author":"HG Vogel","year":"1997","unstructured":"Vogel HG, Gang HVW (1997) Drug discovery and evaluation (pharmacological assay), 2nd edn. Verlog, Heidelberg","edition":"2"},{"key":"10182_CR31","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:42717. https:\/\/doi.org\/10.1038\/srep42717","journal-title":"Sci Rep"},{"key":"10182_CR32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/s0169-409x(00)00129-0","volume":"46","author":"CA Lipinski","year":"2001","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Delivery Rev 46:3\u201326. https:\/\/doi.org\/10.1016\/s0169-409x(00)00129-0","journal-title":"Adv Drug Delivery Rev"},{"key":"10182_CR33","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1023\/a:1020444330011","volume":"19","author":"YH Zhao","year":"2002","unstructured":"Zhao YH, Abraham MH, Le J, Hersey A, Luscombe CN, Beck G, Sherborne B, Cooper I (2002) Rate limited steps of human oral absorption and QSAR studies. Pharm Res 19:1446\u20131457. https:\/\/doi.org\/10.1023\/a:1020444330011","journal-title":"Pharm Res"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-021-10182-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-021-10182-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-021-10182-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T18:11:42Z","timestamp":1651601502000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-021-10182-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,23]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["10182"],"URL":"https:\/\/doi.org\/10.1007\/s11030-021-10182-x","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,23]]},"assertion":[{"value":"18 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"There is no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}